<us-patent-grant lang="EN" dtd-version="v4.2 2006-08-23" file="US07297805-20071120.XML" status="PRODUCTION" id="us-patent-grant" country="US" date-produced="20071106" date-publ="20071120">
<us-bibliographic-data-grant>
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07297805</doc-number>
<kind>B2</kind>
<date>20071120</date>
</document-id>
</publication-reference>
<application-reference appl-type="utility">
<document-id>
<country>US</country>
<doc-number>11152802</doc-number>
<date>20050614</date>
</document-id>
</application-reference>
<us-application-series-code>11</us-application-series-code>
<us-term-of-grant>
<us-term-extension>200</us-term-extension>
</us-term-of-grant>
<classifications-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20060101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>C</section>
<class>07</class>
<subclass>F</subclass>
<main-group>11</main-group>
<subgroup>00</subgroup>
<symbol-position>F</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20071120</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20060101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>C</section>
<class>08</class>
<subclass>F</subclass>
<main-group>4</main-group>
<subgroup>69</subgroup>
<symbol-position>L</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20071120</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
</classifications-ipcr>
<classification-national>
<country>US</country>
<main-classification>556 35</main-classification>
<further-classification>556 57</further-classification>
<further-classification>502103</further-classification>
<further-classification>502167</further-classification>
<further-classification>526161</further-classification>
<further-classification>526165</further-classification>
</classification-national>
<invention-title id="d0e53">Chromium complexes and their use in olefin polymerization</invention-title>
<references-cited>
<citation>
<patcit num="00001">
<document-id>
<country>US</country>
<doc-number>5451645</doc-number>
<kind>A</kind>
<name>Reagen et al.</name>
<date>19950900</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>526 97</main-classification></classification-national>
</citation>
<citation>
<patcit num="00002">
<document-id>
<country>US</country>
<doc-number>5550305</doc-number>
<kind>A</kind>
<name>Wu</name>
<date>19960800</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>585513</main-classification></classification-national>
</citation>
<citation>
<patcit num="00003">
<document-id>
<country>US</country>
<doc-number>6037297</doc-number>
<kind>A</kind>
<name>Stibrany et al.</name>
<date>20000300</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>502155</main-classification></classification-national>
</citation>
<citation>
<patcit num="00004">
<document-id>
<country>US</country>
<doc-number>6180788</doc-number>
<kind>B1</kind>
<name>Stibrany</name>
<date>20010100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>544225</main-classification></classification-national>
</citation>
<citation>
<patcit num="00005">
<document-id>
<country>US</country>
<doc-number>6461994</doc-number>
<kind>B1</kind>
<name>Gibson et al.</name>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>502155</main-classification></classification-national>
</citation>
<citation>
<patcit num="00006">
<document-id>
<country>US</country>
<doc-number>6465386</doc-number>
<kind>B1</kind>
<name>Maddox et al.</name>
<date>20021000</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>502155</main-classification></classification-national>
</citation>
<citation>
<patcit num="00007">
<document-id>
<country>US</country>
<doc-number>6501000</doc-number>
<kind>B1</kind>
<name>Stibrany et al.</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>585511</main-classification></classification-national>
</citation>
<citation>
<patcit num="00008">
<document-id>
<country>US</country>
<doc-number>2002/0045790</doc-number>
<kind>A1</kind>
<name>Stibrany et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>585521</main-classification></classification-national>
</citation>
<citation>
<patcit num="00009">
<document-id>
<country>EP</country>
<doc-number>1238989</doc-number>
<kind>A2</kind>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00010">
<document-id>
<country>JP</country>
<doc-number>2000219704</doc-number>
<kind>A</kind>
<date>20000800</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00011">
<document-id>
<country>WO</country>
<doc-number>WO0069923</doc-number>
<date>20001100</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00012">
<document-id>
<country>WO</country>
<doc-number>WO 2004083263</doc-number>
<kind>A</kind>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00013">
<document-id>
<country>WO</country>
<doc-number>WO 2005111099</doc-number>
<kind>A</kind>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00014">
<othercit>Ruether et al, “Synthesis, characterization and catalytic behaviour of a novel class of chromium (III) and vanadium (III) complexes containing bi- and tri-dentate imidazole chelating ligands: a comparative study”, Journal of the Chemical Society, Dalton Trans., vol. 24, 2002, pp. 4684-4693.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00015">
<othercit>Stibrany et al., “Cu Catalysts for Homo- and Copolymerization of Olefins and Acrylates”, American Chemical Society, vol. 857, 2003, pp. 222-230.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00016">
<othercit>Broughton, et al. “Tetrahedral coordination by a seven-membered chelate ring”, Inorganica Chimica Acta, vol. 275/276, 1998, pp. 279-288.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00017">
<othercit>Small, et al., “New Chromium Complexes for Ethylene Oligomerization: Extended Use of Tridentate Ligands in Metal-Catalyzed Olefin Polymerization”, American Chemical Society, Macromolecules 2004, 37, pp. 4375-4386.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00018">
<othercit>Esteruelas, et als., “Preparation, Structure, and Ethylene Polymerization Behavior of Bis(imino)pyridyl Chromium(III) Complexes” American Chemical Society, Oranometallics 2003, vol. 22, pp. 395-406.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00019">
<othercit>Ceniceros-Gomez, et als., “Synthesis, X-ray and spectroscopic characterization of chromium(III) coordination compounds with benzimidazolic ligands” Polyhedron, vol. 19, (2000) pp. 1821-1827.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00020">
<othercit>Crane, et al., “Tripodal Benzimidazolate Complexes of Tricarbonylmolybdenum(o) and of Iron(III)” J. Chem. Society, Dalton Trans., 1990, pp. 3647-3653.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00021">
<othercit>Batra et al, “Synthesis and Characterization of Iron(III) Complexes with Tridentate Ligands Containing N<sub>2</sub>O/N<sub>2</sub>S Donor Sites”, Polyhedron vol. 12, No. 21, (1993) pp. 2635-2643.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00022">
<othercit>Addison, et al., “New Iron(II) Spin-crossover Complexes with Heterocyclic Amine-derived Ligands and STEPS Experiments on Photogenerated Metastable High-spin States”, J. Chem. Soc., Dalton Trans., 1987, pp. 2621-2630.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00023">
<othercit>Ruther, et als., “Novel Chromium(III) Complexes Containing Imidazole-Based Chelate Ligands with Varying Donor Sets: Synthesis and Reactivity”, American Chem. Soc., Organometallics 2001, vol. 20, pp. 1247-1250.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
</references-cited>
<number-of-claims>7</number-of-claims>
<us-exemplary-claim>1</us-exemplary-claim>
<us-field-of-classification-search>
<classification-national>
<country>US</country>
<main-classification>556 35</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>556 57</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>502103</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>502167</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>526161</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>526165</main-classification>
</classification-national>
</us-field-of-classification-search>
<us-related-documents>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60583881</doc-number>
<kind>00</kind>
<date>20040629</date>
</document-id>
</us-provisional-application>
<related-publication>
<document-id>
<country>US</country>
<doc-number>20050288464</doc-number>
<kind>A1</kind>
<date>20051229</date>
</document-id>
</related-publication>
</us-related-documents>
<parties>
<applicants>
<applicant sequence="001" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Kacker</last-name>
<first-name>Smita</first-name>
<address>
<city>Houston</city>
<state>TX</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
<applicant sequence="002" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Berluche</last-name>
<first-name>Enock</first-name>
<address>
<city>Phillipsburg</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
<applicant sequence="003" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Stibrany</last-name>
<first-name>Robert T.</first-name>
<address>
<city>Long Valley</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
<applicant sequence="004" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Sissano</last-name>
<first-name>Joseph A.</first-name>
<address>
<city>Leonardo</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
<applicant sequence="005" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Baugh</last-name>
<first-name>Lisa S.</first-name>
<address>
<city>Ringoes</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
</applicants>
<agents>
<agent sequence="01" rep-type="attorney">
<addressbook>
<last-name>Migliorini</last-name>
<first-name>Robert A.</first-name>
<address>
<country>unknown</country>
</address>
</addressbook>
</agent>
</agents>
</parties>
<assignees>
<assignee>
<addressbook>
<orgname>Exxonmobil Research and Engineering Company</orgname>
<role>02</role>
<address>
<city>Annanadel</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
</assignee>
</assignees>
<examiners>
<primary-examiner>
<last-name>Lu</last-name>
<first-name>Caixia</first-name>
<department>1713</department>
</primary-examiner>
</examiners>
</us-bibliographic-data-grant>
<abstract id="abstract">
<p id="p-0001" num="0000">A composition having the formula I</p>
<p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001">
<img id="EMI-C00001" he="27.01mm" wi="69.93mm" file="US07297805-20071120-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
<br/>
where R<sup>1 </sup>and R<sup>2 </sup>are independently hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, C<sub>1 </sub>to C<sub>12 </sub>alkoxy, F, Cl, SO<sub>3</sub>, C<sub>1 </sub>to C<sub>12 </sub>perfluoroalkyl, and N(CH<sub>3</sub>)<sub>2</sub>,
<br/>
R<sup>3 </sup>is independently selected from the group consisting of hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, and 2,2,2-trifluoroethyl,
<br/>
A is —C(R<sup>4</sup>)—, —(CH<sub>2</sub>)<sub>x</sub>—, —(CH<sub>2</sub>)<sub>x</sub>NH(CH<sub>2</sub>)<sub>x</sub>—, or —CY<sub>2</sub>CY<sub>2</sub>—, where R<sup>4 </sup>is a hydrocarbyl, halosubstituted hydrocarbyl, or alkoxy group of from 1 to 12 carbon atoms, x is an integer from 1 to 12, and Y is halogen,
<br/>
and
<br/>
X is halogen, triflate, acetate, trifluoroacetate, hydride, or tetrafluoroborate.
<br/>
When combined with an activating co-catalyst is useful in polymerizing olefinic monomers.
</p>
</abstract>
<description id="description">
<?RELAPP description="Other Patent Relations" end="lead"?>
<p id="p-0003" num="0001">This application claims the benefit of U.S. Provisional Application No. 60/583,881 filed Jun. 29, 2004.</p>
<?RELAPP description="Other Patent Relations" end="tail"?>
<?BRFSUM description="Brief Summary" end="lead"?>
<heading id="h-0001" level="1">FIELD OF INVENTION</heading>
<p id="p-0004" num="0002">The present invention is directed toward chromium complexes and their use in olefin polymerization. More specifically the invention is directed toward chromium trihalide complexes having bis-benzimidazole ligands and their use in olefin polymerization.</p>
<heading id="h-0002" level="1">BACKGROUND OF INVENTION</heading>
<p id="p-0005" num="0003">Nitrogen-based chelates of transition metals such as Ti, Ni, Pd, Co and Fe have been actively investigated in recent years as olefin polymerization catalysts. Those incorporating bidentate α-diimine and tridentate bisminopyridine ligands have been found to be highly active catalysts for olefin polymerization.</p>
<p id="p-0006" num="0004">More recently, similar investigations of coordination chemistry and catalysis have been extended to chromium (III) complexes containing certain imidizole-based chelate ligands. These complexes, when activated with methyl aluminoxane (“MAO”) were found to catalyze the oligomerization of ethylene. (See Ruther et al, Organometallics, 2001, 20, 1247-1250).</p>
<p id="p-0007" num="0005">Despite the advances made in catalyst systems employing chromium, there is a continuing need for new catalysts that will provide a greater degree of control over polymerization processes. Homogenous, chromium-based catalysts are believed to possess the potential of providing better control over polymerization processes than many other organometallic catalysts. For example, a neutral nickel (II) catalyst containing bidentate monoanionic ligands produce linear α-olefins with a very wide range Schulz-Flory type distribution. An object of the present invention, therefore, is to provide novel chromium based catalysts useful in the polymerization of olefins.</p>
<heading id="h-0003" level="1">SUMMARY OF INVENTION</heading>
<p id="p-0008" num="0006">In one embodiment the invention is a composition having the formula</p>
<p id="p-0009" num="0007"><chemistry id="CHEM-US-00002" num="00002">
<img id="EMI-C00002" he="27.01mm" wi="69.93mm" file="US07297805-20071120-C00002.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
<br/>
where R<sup>1 </sup>and R<sup>2 </sup>are independently hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, C<sub>1 </sub>to C<sub>12 </sub>alkoxy, F, Cl, SO<sub>3</sub>, C<sub>1 </sub>to C<sub>12 </sub>perfluoroalkyl, and N(CH<sub>3</sub>)<sub>2</sub>,
<br/>
R<sup>3 </sup>is independently selected from the group consisting of hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, and 2,2,2-trifluoroethyl,
<br/>
A is —C(R<sup>4</sup>)—, —(CH<sub>2</sub>)<sub>x</sub>—, —(CH<sub>2</sub>)<sub>x</sub>NH(CH<sub>2</sub>)<sub>x</sub>—, or —CY<sub>2</sub>CY<sub>2</sub>—,
<br/>
where R<sup>4 </sup>is a hydrocarbyl, halosubstituted hydrocarbyl, or alkoxy group of from 1 to 12 carbon atoms, x is an integer from 1 to 12, and Y is halogen,
<br/>
and
<br/>
X is halogen, triflate, acetate, trifluoroacetate, hydride, or tetrafluoroborate.
</p>
<p id="p-0010" num="0008">In another embodiment the invention is a catalyst comprising the reaction product of a compound of formula I and an activating co-catalyst.</p>
<p id="p-0011" num="0009">In yet another embodiment a method for making polyolefins is provided which includes contacting olefinic monomers under polymerization conditions with a catalyst composition comprising a composition having formula I and an activating co-catalyst.</p>
<p id="p-0012" num="0010">These and other features, aspects and advantages of the present invention will become better understood with regard to the following description and appended claims.</p>
<?BRFSUM description="Brief Summary" end="tail"?>
<?DETDESC description="Detailed Description" end="lead"?>
<heading id="h-0004" level="1">DETAILED DESCRIPTION</heading>
<p id="p-0013" num="0011">The invention provides novel chromium bis-benzimidazole complexes which, when used with an activating co-catalyst, provides a novel catalyst composition.</p>
<p id="p-0014" num="0012">The chromium complexes of the invention are represented by the formula</p>
<p id="p-0015" num="0013"><chemistry id="CHEM-US-00003" num="00003">
<img id="EMI-C00003" he="27.01mm" wi="69.93mm" file="US07297805-20071120-C00003.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
<br/>
where R<sup>1 </sup>and R<sup>2 </sup>are independently, hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, and aryl, C<sub>1 </sub>to C<sub>12 </sub>alkoxy, F, Cl, SO<sub>3</sub>, C<sub>1 </sub>to C<sub>12 </sub>perfluoroalkyl, and N(CH<sub>3</sub>)<sub>2</sub>,
<br/>
R<sup>3 </sup>is independently selected from the group consisting of hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, and 2,2,2-trifluoroethyl,
<br/>
A is —C(R<sup>4</sup>)—, —(CH<sub>2</sub>)<sub>x</sub>—, —(CH<sub>2</sub>)<sub>x</sub>NH(CH<sub>2</sub>)<sub>x</sub>—, or —CY<sub>2</sub>CY<sub>2</sub>—,
<br/>
where R<sup>4 </sup>is a hydrocarbyl, halosubstituted hydrocarbyl, or alkoxy group of from 1 to 12 carbon atoms, x is an integer from 1 to 12, and Y is halogen, and
<br/>
X is halogen, triflate, acetate, trifluoroacetate, hydride, or tetrafluoroborate.
</p>
<p id="p-0016" num="0014">Preferred compositions are those in which R<sup>3 </sup>is an alkyl group, especially n-butyl; where R<sup>1 </sup>and R<sup>2 </sup>are hydrogen or methyl; where A is —C(C<sub>4</sub>H<sub>9</sub>)—, or —CF<sub>2</sub>CF<sub>2</sub>—; and X is chlorine.</p>
<p id="p-0017" num="0015">The compounds of the invention are made by reacting Cr(III) halide, e.g., CrCl<sub>3 </sub>or CrCl<sub>3</sub>•(THF)<sub>3 </sub>(THF=tetrahydrofuran), with the appropriate ligand. This is done by adding the chromium compound to a solvent or diluent and then adding the ligand to the solvent or diluent. Suitable solvents or diluents include liquid or supercritical gases such as CO<sub>2</sub>, tetrahydrofuran, straight and branched alkanes like isobutane, butane, pentane, hexane and mixtures thereof; cyclic and alicyclic hydrocarbons like cyclohexane, methylcyclohexane; halogenated hydrocarbons such as chlorobenzene; perfluorinated C<sub>4-10 </sub>alkanes; and aromatic hydrocarbons like toluene. The resulting chromium complex is separated by removal of, or precipitation from, the diluent or solvent.</p>
<p id="p-0018" num="0016">Optionally, the chromium complex may be prepared in the solvent or diluent to be used for the polymerization. In this instance, the chromium complex and the co-catalyst are typically combined in the solvent or diluent used for the polymerization immediately before adding the olefinic monomer to be polymerized.</p>
<p id="p-0019" num="0017">As indicated the following ligands are preferred: 1,1′-bis(1-butylbenzimidazol-2-yl)pentane; 1,2-bis(1-butylbenzimidazol-2-yl)-1,1,2,2-tetrafluoroethane; and 1,1′-bis(1-butyl-4-methylbenzimidazol-2-yl)pentane.</p>
<p id="p-0020" num="0018">1,1′-Bis(1-butylbenzimidazol-2-yl)pentane has the structure II:</p>
<p id="p-0021" num="0019"><chemistry id="CHEM-US-00004" num="00004">
<img id="EMI-C00004" he="23.03mm" wi="69.93mm" file="US07297805-20071120-C00004.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
</p>
<p id="p-0022" num="0020">1,2-Bis(1-butylbenzimidazol-2-yl)-1,1,2,2 tetrafluoroethane has the structure III:</p>
<p id="p-0023" num="0021"><chemistry id="CHEM-US-00005" num="00005">
<img id="EMI-C00005" he="19.47mm" wi="69.85mm" file="US07297805-20071120-C00005.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
</p>
<p id="p-0024" num="0022">1,1′-Bis(1-butyl-4 methyl benzimidazol-2-yl)pentane has the structure IV:</p>
<p id="p-0025" num="0023"><chemistry id="CHEM-US-00006" num="00006">
<img id="EMI-C00006" he="26.59mm" wi="69.85mm" file="US07297805-20071120-C00006.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
</p>
<p id="p-0026" num="0024">The ligands of the invention may be synthesized using techniques known to those skilled in the art. In this regard, see for example, U.S. Pat. No. 6,037,297, herein incorporated by reference.</p>
<p id="p-0027" num="0025">The chromium compositions of the invention are combined with an activating co-catalyst to provide a catalyst useful in polymerizing olefins. Examples of such co-catalysts include aluminum compounds containing an Al—O bond such as the alkylalumoxanes, of which methyl alumoxane (“MAO”) is an example. Other suitable co-catalysts include mixtures of alkyl alumoxane with one or more trialkyl aluminum or trialkyl boron compounds, and mixtures of alkyl alumoxanes with aluminum halides or boron halides and an alkylating agent. Examples of alkylating agents include methyl magnesium chloride and methyl lithium. Typically the alkyl group will range from 1 to about 12 carbon atoms.</p>
<p id="p-0028" num="0026">A preferred activating co-catalyst is methylalumoxane.</p>
<p id="p-0029" num="0027">Olefinic monomers that are useful in forming polymers with the catalyst of the invention include, for example, ethylenically unsaturated monomers, non-conjugated dienes, oligomers and higher molecular weight, vinyl terminated macromers. Representative examples include C<sub>2-20 </sub>olefins, vinylcyclohexane, tetrafluoroethylene, and mixtures thereof. Preferred are C<sub>2-10 </sub>α-olefins such as ethylene and 1-hexene.</p>
<p id="p-0030" num="0028">In general the polymerization is accomplished at temperatures ranging from about −100° C. to 250° C., preferably 0° C. to 250° C., and pressures of from atmospheric to 2000 atmospheres (200 Mpa). Suitable polymerization conditions include those known to be useful for olefin polymerization catalysts when activated by aluminum or boron compounds. Suspension, solution, slurry, gas phase or other process conditions may be employed if desired.</p>
<p id="p-0031" num="0029">The polymerization typically will be conducted in the presence of a solvent. Suitable solvents include toluene, methylene chloride, chlorobenzene, THF, and the like.</p>
<p id="p-0032" num="0030">The polymerization will be conducted for a time sufficient to form the polymer and the polymer is recovered by techniques known in the art and illustrated in the examples hereinafter.</p>
<p id="p-0033" num="0031">In the following examples involving ligands and catalysts, stage melting points were determined visually and are uncorrected. DSC melting points were taken with a TA Instruments 2920 calorimeter using a scan rate of 10° C./minute. Elemental analyses were carried out by QTI, Whitehouse, N.J. Field desorption mass spectra were obtained on a VG-ZAB system. Infrared spectra were obtained on a Mattson Galaxy Series 5000 spectrometer running First software. NMR spectra were obtained using a Bruker Avance 400 Ultrashield spectrometer, with default calibration to CFCl<sub>3 </sub>used as a standard for <sup>19</sup>F spectra. Solid-state NMR experiments were carried out using a Chemagnetics CMXII-200 spectrometer.</p>
<heading id="h-0005" level="1">EXAMPLE 1</heading>
<heading id="h-0006" level="1">Synthesis of 1,1′-bis(1-butylbenzimidazol-2-yl)pentane (TriBu-BBIM)</heading>
<p id="p-0034" num="0032">In a 250 mL 35/25 ball joint flask, 1,2-phenylenediamine (54 mmol) was combined with malonic acid (2 equivalents). Polyphosphoric acid (˜100 g) was added directly to the solid mixture. The flask was fitted with an air-driven mechanical stirring shaft and heated to 160° C. under a nitrogen purge maintained with a septum and needle. The molten mixture was stirred for 7 hours and subsequently poured slowly into a large (1 L) excess of cold water. A Waring™ blender was used to grind the solid product/water slurry. The water was then neutralized to a pH of ˜8 with ammonium hydroxide. The product, 1,1′-bis(1-butylbenzimidazol-2-yl)pentane, was isolated by filtration and dried in a vacuum oven at 110° C. for several days. A 23.00 g (0.093 mol) quantity of this product was placed in a 300 mL round bottom flask with a side arm. This was followed by the addition of 25 mL of anhydrous DMSO. The flask was then fitted with a bubbler. Under a flow of nitrogen, 6.0 g of sodium hydride (60% dispersion in mineral oil) was added over one hour while stirring at 0° C. The reaction was allowed to warm to room temperature, and 25.00 mL (0.220 mol) of 1-iodobutane was added dropwise over one hour. The reaction mixture was left stirring under nitrogen for 48 hours. The reaction mixture was quenched with water and then an additional 400 mL of water was added. After stirring for one half hour, a biphasic solution was obtained. The organic layer was extracted with cyclohexane and was washed with water. The volatiles were removed from the cyclohexane phase under reduced pressure to leave a dark oil. The oil was chromatographed on silica gel with methylene chloride as the eluent. The solvent was removed under reduced pressure from the combined eluents to give a very pale-pink oil that crystallized upon standing at room temperature (C<sub>27</sub>H<sub>36</sub>N<sub>4</sub>, FW=416.61). Yield: 20.44 g (67%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.79 (m, 2H), 7.24 (m, 6H), 4.88 (t, J=7.9 Hz, 1H), 4.16 (dsp, J=5.0 Hz, J=40.9 Hz, 4H), 2.59 (m, 2H), 1.44 (m, 4H), 1.16 (m, 4H), 1.10 (m, 2H), 0.99 (m, 2H), 0.89 (t, J=6.8 Hz, 3 H), 0.61 (t, J=7.0 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 151.8, 142.4, 135.6, 122.6, 122.0, 119.6, 109.7, 44.0, 40.9, 31.5, 31.2, 30.1, 22.5, 20.0, 14.0, 13.4. IR (KBr pellet, cm<sup>−1</sup>): 3050 (m), 2955 (m), 2931 (m), 2862 (m), 1613 (w), 1501 (m), 1458 (s), 1400 (s), 1331 (m), 1285 (m), 1008 (m), 933 (m), 743 (s), 434 (w). R<sub>f</sub>=0.73 (ethyl acetate). FD-MS m/z (%): 416.1 (M<sup>+</sup>). Melting point (stage) 82-83° C.</p>
<heading id="h-0007" level="1">EXAMPLE 2</heading>
<heading id="h-0008" level="1">Synthesis of [1,1′-bis(1-butylbenzimidazol-2-yl)pentane]CrCl<sub>3 </sub>((TriBu-BBIM)CrCl<sub>3</sub>) (A)</heading>
<p id="p-0035" num="0033">CrCl<sub>3</sub>•(THF)<sub>3 </sub>(0.27 g, 0.72 mmol) was weighed into a flask equipped with a stirrer under argon. THF (15 mL) was added to the flask followed by the ligand triBu-BBIM (0.33 g, 0.79 mmol). The solution was stirred overnight at room temperature. At the end of this time period, the solution was added to 100 mL of diethyl ether. The precipitate was filtered and washed with ether and hexane and dried under vacuum at room temperature. Yield: 0.4 g, 87% (C<sub>27</sub>H<sub>36</sub>N<sub>4</sub>CrCl<sub>3</sub>, FW=574.96). NMR spectra in CDCl<sub>3 </sub>and THF showed broad peaks, indicating a paramagnetic center. IR (KBr pellet, cm<sup>−1</sup>): 2959.0 (s), 2872.2 (m), 1614.5 (m), 1597.2 (w), 1494.9 (s), 1479.5 (s), 1460.2 (s), 1435.1 (m), 1375.3 (w), 1338.7 (w), 1275.0 (m), 750.3 (s). Melting point (stage) 215° C.</p>
<heading id="h-0009" level="1">EXAMPLE 3</heading>
<heading id="h-0010" level="1">Synthesis of 1,2-bis(1-butylbenzimidazol-2-yl)-1,1,2,2-tetrafluoroethane (DiBu-(C<sub>2</sub>F<sub>4</sub>)-BBIM)</heading>
<p id="p-0036" num="0034">In a 250 mL 35/25 ball joint flask, 1,2-phenylenediamine (5.92 g, 54.7 mmol) was combined with tetrafluorosuccinic acid (5.2 g, 27.36 mmol). Polyphosphoric acid (83 g) was added directly to the solid mixture. The flask was fitted with an air-driven mechanical stirring shaft and heated to 160° C. under a nitrogen purge maintained with a septum and needle. The molten mixture was stirred for 7 hours and subsequently poured slowly into a large (1 L) excess of cold water. A Waring™ blender was used to grind the solid product/water slurry. The water was then neutralized to a pH of ˜8 with ammonium hydroxide. The brown particulate product, 1,2-bis(benzimidazol-2-yl)-1,1,2,2-tetrafluoroethane, was isolated by filtration, dried in a vacuum oven, ground to a fine powder with a mortar and pestle, and once again slurried in ca. 1 L water which was then neutralized to pH 8 with ammonium hydroxide. The solid was again collected by filtration and dried under diffusion pump vacuum at 110° C. for several days (7.96 g, 87%; C<sub>16</sub>H<sub>10</sub>F<sub>4</sub>N<sub>4</sub>, FW=334.27). A small amount of water was still present by <sup>1</sup>H NMR (br s, 3.35 ppm). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO): δ 13.66 (br s, 2 H, N<u style="single">H</u>), 7.67 and 7.34 (each br s, 4H, aryl C—<u style="single">H</u>. <sup>13</sup>C{<sup>1</sup>H} NMR (solid state): δ 142.2, 135.5 (<u style="single">C</u>—N), 124.2, 120.2, 114.4 (aryl) (<u style="single">C</u>═N and <u style="single">C</u>F<sub>2 </sub>not observed). <sup>19</sup>F NMR (d<sub>6</sub>-DMSO, vs. CFCl<sub>3</sub>): δ−110.61. IR (KBr pellet, cm<sup>−1</sup>): 3063 (m), 3011 (m), 2947 (m), 2864 (s), 2749 (s), 2699 (sh), 2647 (s), 2546 (m), 2527 (m), 1942 (w), 1903 (w), 1778 (w), 1622 (w), 1591 (m), 1537 (w), 1492 (m), 1456 (s), 1441 (s), 1389 (w), 1317 (m), 1279 (m), 1231 (m), 1202 (w), 1161 (vs), 1140 (vs), 1030 (m), 1014 (m), 999 (m), 941 (m), 909 (m), 887 (m), 789 (w), 766 (w), 739 (s), 675 (w), 619 (w), 590 (m), 545 (w), 434 (m). Elemental analysis calculated for C<sub>16</sub>H<sub>10</sub>F<sub>4</sub>N<sub>4</sub>: C, 57.49; H, 3.02; F, 22.73; N, 16.76. Found: C, 56.74; H, 2.82; F, 21.95; N, 16.70. FD-MS m/z (%): 334 (M<sup>+</sup>, 100), 167 (C<sub>8</sub>H<sub>5</sub>F<sub>2</sub>N<sub>2</sub>, 6). Melting point (DSC, maximum): 383° C.</p>
<p id="p-0037" num="0035">Subsequently, 1,2-bis(benzimidazol-2-yl)-1,1,2,2-tetrafluoroethane (4.02 g, 12.03 mmol) was degassed on a vacuum line in a 250 mL round-bottomed flask and flushed with argon. Anhydrous, nitrogen-sparged DMSO (135 mL) was cannulated into the flask, resulting in a purple solution. Separately, a 500 mL three-necked flask equipped with a stirbar, addition funnel, vacuum adapter, and a septum was assembled in the glove box. Sodium hydride (powder, 1.15 g, 48.10 mmol) was added, and the flask was placed under argon on a Schlenk line. Anhydrous DMSO (35 mL) was added via cannula to form a slurry. The bis-benzimidazole solution was then cannulated into the addition funnel and added dropwise to the sodium hydride slurry over a 30 minute period at 0° C., giving a cloudy black solution. The reaction mixture was warmed to room temperature over a 2 hour period and sparged iodobutane (8.86 g, 48.12 mmol) was added. The slurry was stirred overnight at room temperature and the resultant clear amber, viscous solution was poured into 300 mL of deionized water. The organic products were isolated by extraction with 3×200 mL of cyclohexane, followed by back-extraction of the combined organic layers with 1×200 mL deionized water. Removal of cyclohexane gave 4.725 g (88%) of the light tan product, 1,2-bis(1-butylbenzimidazol-2-yl)-1,1,2,2-tetrafluoroethane, which was recrystallized from methanol at −10° C. (3.795 g, 71%; C<sub>24</sub>H<sub>26</sub>F<sub>4</sub>N<sub>4</sub>, FW=446.48). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.80 (d, J=8.1 Hz, 2H), 7.44 (d, J=8.1 Hz, 2H), 7.38 (tr, J=7.5 Hz, 2H), 7.31 (tr, J=7.6 Hz, 2H) (aryl), 4.39 (tr, J=7.8 Hz, 4H, <u style="single">C</u>H<sub>2</sub>N), 1.87 (5, J=7.8 Hz, 4H, C<u style="single">H</u><sub>2</sub>CH<sub>2</sub>N), 1.44 (6, j=7.5 Hz, 4 H, C<u style="single">H</u><sub>2</sub>CH<sub>3</sub>), 0.96 (tr, J=7.36, 6H, C<u style="single">H</u><sub>3</sub>). <sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, assigned by DEPT): δ 141.63 (aryl <u style="single">C</u>—N), 140.89 (tr, J<sub>CF</sub>=28.4 Hz, <u style="single">C</u>═N), 135.40 (aryl <u style="single">C</u>-N), 124.53 and 122.95 (aryl o- to C—N), 121.11 (aryl m- to C—N), 112.84 (tr of tr, J<sub>CF</sub>=253.4 and 34.4 Hz, <u style="single">C</u>F<sub>2</sub>), 110.39 (aryl m- to C—N), 45.27 (<u style="single">C</u>H<sub>2</sub>N), 32.07 (<u style="single">C</u>H<sub>2</sub>CH<sub>2</sub>N), 19.94 (<u style="single">C</u>H<sub>2</sub>CH<sub>3</sub>), 13.46 (<u style="single">C</u>H<sub>3</sub>). <sup>19</sup>F NMR (CDCl<sub>3</sub>, vs. CFCl<sub>3</sub>): δ-107.52. IR (KBr pellet, cm<sup>−1</sup>): 3082 (w), 3055 (m), 3017 (m), 2965 (s), 2936 (s), 2874 (s), 2737 (w), 1939 (w), 1896 (w), 1861 (w), 1811 (w), 1771 (w), 1734 (w), 1682 (w), 1615 (m), 1588 (m), 1499 (s), 1487 (s), 1464 (sh), 1452 (vs), 1424 (s), 1373 (s), 1335 (s), 1283 (w), 1248 (s), 1227 (m), 1167 (vs), 1142 (vs), 1101 (vs), 1005 (m), 980 (w), 963 (w), 916 (s), 893 (s), 783 (m), 739 (vs), 669 (m), 598 (m), 548 (w), 440 (m). Elemental analysis calculated for C<sub>24</sub>H<sub>26</sub>F<sub>4</sub>N<sub>4</sub>: C, 64.56; H, 5.87; F, 17.02; N, 12.55. Found: C, 64.32; H, 5.77; F, 16.93; N, 12.46. Melting point (stage): 112° C. FD-MS m/z (%): 446 (M<sup>+</sup>, 100).</p>
<heading id="h-0011" level="1">EXAMPLE 4</heading>
<heading id="h-0012" level="1">Synthesis of [1,2-bis(1-butylbenzimidazol-2-yl)-1,1,2,2-tetrafluoroethane]CrCl<sub>3 </sub>(DiBu-(C<sub>2</sub>F<sub>4</sub>)-BBIM)CrCl<sub>3</sub>) (B)</heading>
<p id="p-0038" num="0036">THF (5 mL) was added to DiBu-(C<sub>2</sub>F<sub>4</sub>)-BBIM (0.381 g, 0.053 mmol) in an argon-flushed 250 mL round-bottomed flask. The ligand was only partially soluble resulting in a slurry. CrCl<sub>3</sub>•(THF)<sub>3 </sub>(0.32 g, 0.853 mmol) in THF (10 mL) was added to the slurry. The mixture was stirred overnight at room temperature. Subsequently, methylene chloride (5 mL) was added and the resulting purple solution was stirred for 2 days. All solvents were then removed under vacuum, and the solids were washed with diethylether and hexane and dried under vacuum at room temperature to give [1,2-bis(1-butylbenzimidazol-2-yl)-1,1,2,2-tetrafluoroethane]CrCl<sub>3 </sub>as a light purple solid (0.52 g, 60%, C<sub>24</sub>H<sub>26</sub>F<sub>4</sub>N<sub>4</sub>CrCl<sub>3</sub>, FW=604.84). IR (KBr pellet, cm<sup>−1</sup>): 3010 (s), 2890 (s), 1599.1 (s). 1498.8 (s), 1487.2 (s), 1452.5 (s), 1425.5 (s), 1373.4 (s), 1334.8 (s), 1248.0 (s), 1226.8 (m), 1167.0 (s), 1141.9 (s), 1103.4 (s), 1045.5 (w), 1006.9 (m), 962.5 (w), 916.2 (w), 993.1 (w), 862.2 (s), 796.7 (w), 744.6 (s). Melting point (stage) 125° C.</p>
<heading id="h-0013" level="1">EXAMPLE 5</heading>
<heading id="h-0014" level="1">Synthesis of 1,1-bis(1-butyl-4-methylbenzimidazol-2-yl)pentane (TriBu-4,4′-diMe-BBIM)</heading>
<p id="p-0039" num="0037">The ligand precursor bis(4-methyl-2-benzimidazolyl)methane was first prepared in a procedure analogous to that given for 1,2-bis(benzimidazol-2-yl)-1,1,2,2-tetrafluoroethane in Example 3. The reagents used were: 2,3-diaminotoluene (15.26 g, 0.125 moles), malonic acid (6.53 g, 0.063 moles), and polyphosphoric acid (40 g). Upon heating, the contents of the flask had the viscosity of milk and turned a deep bluish purple color. The compound bis(4-methyl-2-benzimidazolyl)methane was isolated as a purple blue solid (11.35 g, 66% yield, C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>, FW=276.32). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO): δ 7.30 (d, J=7.9 Hz, 2 H), 7.03 (tr, J=7.6, 2 H), 6.94 (d, J=7.2, 2H) (aryl C<u style="single">H</u>), 4.46 (s, 2 H, <u style="single">H</u><sub>2</sub>), 2.50 (s, theoretical 12 H, Me). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.30 (d, J=8), 7.04 (t, J=8), 6.94 (d, J=8) (aryl), 4.48 (s, C<u style="single">H</u><sub>2</sub>), 2.49 (s, Me). <sup>1</sup>H NMR (d<sub>7</sub>-DMF): 7.35 (d, J=8.0, 2 H), 7.05 (t, J=7.6, 2 H), 6.96 (d, J=7.0, 2 H) (aryl), 4.59 (br s, 2 H, C<u style="single">H</u><sub>2</sub>), 2.51 (s, 6H, Me). <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, assigned by DEPT): δ 149.73 (<u style="single">C</u>═N), 138.39, 138.01 (br, aryl <u style="single">C</u>—N), 124.50 (aryl <u style="single">C</u>—Me), 121.93, 121.58, 111.98 (aryl <u style="single">C</u>—H), 29.35 (CH<sub>2</sub>), 16.80 (CH<sub>3</sub>). <sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>): δ 150.1 (<u style="single">C</u>═N), 138.7, 138.4 124.8, 121.9, 121.6 112.3 (aryl carbons), 29.7 (bridging <u style="single">C</u>H<sub>2</sub>), 17.1 (<u style="single">C</u>H<sub>3 </sub>on phenyl rings). IR (KBr pellet, cm<sup>−1</sup>): 3377 (s), 3169 (sh), 3022 (s), 2918 (s), 2857 (sh), 2745 (s), 2693 (sh), 1904 (w), 1829 (w), 1761 (w), 1620 (w), 1533 (m), 1439 (vs), 1418 (sh), 1319 (w), 1277 (m), 1231 (m), 1157 (w), 1078 (w), 1022 (w), 783 (m), 745 (s). Elemental analysis calculated for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>: C, 73.89; H, 5.84; N, 20.27. Found: C, 69.57; H, 5.49; N, 19.28 (incomplete combustion; calculated C:H:N ratio 12.7:1.0:3.5; found C:H:N ratio 12.7:1.0:3.5). FD-MS m/z (%): 277 (M<sup>+</sup>, 100); 291 (13%, assigned as impurity with backbone CH<sub>2 </sub>oxidized to C═O). Melting point (stage): appears to decompose by darkening, 145-165° C. Melting point (DSC, maximum): 282° C. (broad).</p>
<p id="p-0040" num="0038">Subsequently, bis(4-methyl-2-benzimidazolyl)methane (10.0 g, 36.2 mmol) was reacted with NaH (3.47 g, 145 mmol) and iodobutane (12.4 mL, 20.1 g, 109 mmol) in anhydrous DMSO following a procedure analogous to the procedure given for 1,2-bis(1-butylbenzimidazol-2-yl)-1,1,2,2-tetrafluoroethane in Example 3. Following extraction, the burgundy-black product mixture (14.04 g, 87%) was eluted in batches through a silica gel column using 90:10 CH<sub>2</sub>Cl<sub>2</sub>/ethyl acetate. The collected product (R<sub>f</sub>˜0.7) was not completely separable from impurities at R<sub>f</sub>˜0.25-0.30 and the solvent front, and was subsequently eluted through a large neutral alumina column (J. T. Baker Type IB; 41 mm ID; stationary phase height ˜40 cm) using CH<sub>2</sub>Cl<sub>2</sub>. Following elution of a yellow byproduct, the pure ligand was collected as a red oil (R<sub>f</sub>˜0.74, 6.00 g, 37%) and dried at 60° C. under high vacuum (C<sub>29</sub>H<sub>40</sub>N<sub>4</sub>, FW=444.65). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.12-7.01 (m, 6 H, aryl), 4.90 (t, J=7.8 Hz, 1 H, backbone C <u style="single">H</u>), 4.16 (m, 4 H, butyl C<u style="single">H</u><sub>2</sub>N), 2.68 (s, 6 H, aryl CH<sub>3</sub>), 2.57 (br apparent q, J=7.7 Hz, 2 H, backbone butyl C<u style="single">H</u><sub>2</sub>CH), 1.45-1.43 (m, 4 H), 1.20-1.15 (m, 4 H), 1.04-0.95 (br m, 4 H) (butyl C<u style="single">H</u><sub>2</sub>), 0.90 (t, J=7.0 Hz, 3 H, backbone butyl CH<sub>3</sub>), 0.61 (t, J=7.3 Hz, 6 H, N-butyl C<u style="single">H</u><sub>3</sub>). <sup>13</sup>C{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, assigned by DEPT): δ 151.23 (<u style="single">C</u>═N), 141.76 and 135.23 (aryl <u style="single">C</u>—N), 129.58 (aryl <u style="single">C</u>-Me), 122.23, 122.17, 107.10 (aryl), 44.01 (<u style="single">C</u>H<sub>2</sub>N), 40.96 (backbone <u style="single">C</u>H), 31.47 (N-butyl <u style="single">C</u>H<sub>2</sub>), 31.12, 30.12, 22.65 (backbone butyl <u style="single">C</u>H<sub>2</sub>), 20.00 (N-butyl <u style="single">C</u>H<sub>2</sub>), 16.70 (aryl <u style="single">C</u>H<sub>3</sub>), 13.97 (backbone butyl <u style="single">C</u>H<sub>3</sub>), 13.33 (N-butyl <u style="single">C</u>H<sub>3</sub>. IR (thin film on NaCl, cm<sup>−1</sup>): 3055 (w, 3027 (w), 2957 (vs), 2932 (vs), 2873 (m), 1733 (w), 1601 (w), 1502 (m), 1459 (s), 1431 (s), 1399 (s), 1379 (m), 1366 (m), 1335 (m), 1268 (m), 1241 (m), 1215 (w), 1152 (w), 1115 (w), 1075 (w), 1037 (w), 970 (w), 947 (w), 904 (w), 872 (w), 780 (m), 749 (s) cm<sup>−1</sup>. Elemental analysis calculated for C<sub>29</sub>H<sub>40</sub>N<sub>4</sub>: C, 78.33; H, 9.07; N, 12.60. Found: C, 78.14; H, 9.03; N, 12.44. FD-MS m/z (%): 444 (M<sup>+</sup>, 100).</p>
<heading id="h-0015" level="1">EXAMPLE 6</heading>
<heading id="h-0016" level="1">Synthesis of [1,1-bis(1-butyl-4-methylbenzimidazol-2-yl)pentane]CrCl<sub>3 </sub>((TriBu-4,4′-diMe-BBIM)CrCl<sub>3</sub>) (C)</heading>
<p id="p-0041" num="0039">This material was prepared following a procedure analogous to example 4. The reagents used were TriBu-4,4′-diMe-BBIM (0.561 g, 1.26 mmol, soluble in THF) and CrCl<sub>3</sub>.(THF)<sub>3 </sub>(0.473 g, 1.26 mmol). [1,1-Bis(1-butyl-4-methylbenzimidazol-2-yl)pentane]CrCl<sub>3 </sub>was isolated as a light purple solid (0.45 g, 95%, C<sub>29</sub>H<sub>40</sub>N<sub>4</sub>CrCl<sub>3</sub>, FW=603.01). IR (KBr pellet, cm<sup>−1</sup>): 1602.9 (s), 1531.6 (w), 1489.1(m), 1456.3 (m), 1043.6 (m), 1010.8 (s), 920.1 (w), 862.2(s), 781.2 (w), 748.4 (w). Melting point (stage): 115° C.</p>
<heading id="h-0017" level="1">EXAMPLE 7</heading>
<heading id="h-0018" level="1">Polymerizations</heading>
<p id="p-0042" num="0040">99.9% pure ethylene (Grade 4.5, 99.995%, BOC Gases) was used as received. Methyl aluminoxane (30 wt % solution in toluene) was used as received from Albemarle. Toluene used as a solvent was dried by passing through purification columns of copper catalyst to remove oxygen and alumina to remove moisture (Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. <i>Organometallics </i>1996, 15, 1518-1520). The polymer products were characterized by <sup>1</sup>H, and <sup>13</sup>C NMR using a Varian INOVA 300 spectrometer with a 5 mm switchable broadband probe. Molecular weights were determined using a Waters Associates 150 C High Temperature gel permeation chromatography chromatograph equipped with three Polymer Laboratories mixed bed Type B columns in 1,2,4-trichlorobenzene at 135° C., using a Waters DRI detector and a polyethylene calibration curve.</p>
<p id="p-0043" num="0041">Polymerizations were run in a 300 mL Parr™ reactor fitted with a mechanical stirrer. Catalyst was weighed in a glass liner under argon in the glove box; then, 75 mL of solvent was added to the catalyst. The reactor was then sealed and brought out of the glove box and attached to the ethylene feed. The specified amount of methyl aluminoxane solution was added to the reactor after dissolving ethylene in the solution at atmospheric pressure. The pressure was then increased to that specified for the run and the temperature for the run was set. At the end of the reaction, excess ethylene was vented, and the reaction was quenched with methanol. After cooling, the polymer was isolated by precipitation into acidic methanol, followed by drying under vacuum. Conditions and results are summarized in Table 1.</p>
<p id="p-0044" num="0042">
<tables id="TABLE-US-00001" num="00001">
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="10">
<colspec colname="1" colwidth="49pt" align="center"/>
<colspec colname="2" colwidth="28pt" align="center"/>
<colspec colname="3" colwidth="35pt" align="center"/>
<colspec colname="4" colwidth="21pt" align="center"/>
<colspec colname="5" colwidth="28pt" align="left"/>
<colspec colname="6" colwidth="21pt" align="center"/>
<colspec colname="7" colwidth="21pt" align="center"/>
<colspec colname="8" colwidth="28pt" align="center"/>
<colspec colname="9" colwidth="35pt" align="center"/>
<colspec colname="10" colwidth="42pt" align="left"/>
<thead>
<row>
<entry namest="1" nameend="10" rowsep="1">TABLE 1</entry>
</row>
<row>
<entry namest="1" nameend="10" align="center" rowsep="1"/>
</row>
<row>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry>Activity,</entry>
<entry/>
</row>
<row>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry>Kg of</entry>
</row>
<row>
<entry/>
<entry/>
<entry>mmol</entry>
<entry>Cr:Al</entry>
<entry/>
<entry>Temp</entry>
<entry>Time,</entry>
<entry>C<sub>2</sub>H<sub>4</sub>,</entry>
<entry>Product/</entry>
<entry>MW (×10<sup>3</sup>),</entry>
</row>
<row>
<entry>Ex. No.</entry>
<entry>Catalyst</entry>
<entry>catalyst</entry>
<entry>ratio</entry>
<entry>Solvent</entry>
<entry>° C.</entry>
<entry>hr</entry>
<entry>psig</entry>
<entry>mol of Cr</entry>
<entry>MWD <sup>a</sup></entry>
</row>
<row>
<entry namest="1" nameend="10" align="center" rowsep="1"/>
</row>
</thead>
<tbody valign="top">
<row>
<entry/>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="10">
<colspec colname="1" colwidth="49pt" align="center"/>
<colspec colname="2" colwidth="28pt" align="center"/>
<colspec colname="3" colwidth="35pt" align="char" char="."/>
<colspec colname="4" colwidth="21pt" align="center"/>
<colspec colname="5" colwidth="28pt" align="left"/>
<colspec colname="6" colwidth="21pt" align="center"/>
<colspec colname="7" colwidth="21pt" align="char" char="."/>
<colspec colname="8" colwidth="28pt" align="center"/>
<colspec colname="9" colwidth="35pt" align="char" char="."/>
<colspec colname="10" colwidth="42pt" align="left"/>
<tbody valign="top">
<row>
<entry>7-1</entry>
<entry>A</entry>
<entry>0.035</entry>
<entry>1:500</entry>
<entry>Toluene</entry>
<entry>50</entry>
<entry>24</entry>
<entry>500</entry>
<entry>40</entry>
<entry>151, 4.4</entry>
</row>
<row>
<entry>7-2</entry>
<entry>A</entry>
<entry>0.035</entry>
<entry>1:300</entry>
<entry>Toluene</entry>
<entry>50</entry>
<entry>24</entry>
<entry>500</entry>
<entry>13</entry>
<entry>140, 8.5</entry>
</row>
<row>
<entry>(1 g of 1-</entry>
</row>
<row>
<entry>hexene added)</entry>
</row>
<row>
<entry>7-3</entry>
<entry>A</entry>
<entry>0.035</entry>
<entry>1:300</entry>
<entry>CH<sub>2</sub>Cl<sub>2</sub></entry>
<entry>50</entry>
<entry>20</entry>
<entry>500</entry>
<entry>507</entry>
<entry>120, 6.6</entry>
</row>
<row>
<entry>7-4</entry>
<entry>A</entry>
<entry>0.017</entry>
<entry>1:260</entry>
<entry>C<sub>6</sub>H<sub>5</sub>Cl</entry>
<entry>50</entry>
<entry>20</entry>
<entry>500</entry>
<entry>124</entry>
<entry>86, 8.1</entry>
</row>
<row>
<entry>7-5</entry>
<entry>A</entry>
<entry>0.017</entry>
<entry>1:260</entry>
<entry>C<sub>6</sub>H<sub>5</sub>Cl</entry>
<entry>24</entry>
<entry>2</entry>
<entry>100</entry>
<entry>95</entry>
<entry>157, 24.7</entry>
</row>
<row>
<entry>7-6</entry>
<entry>A</entry>
<entry>0.017</entry>
<entry>1:260</entry>
<entry>CH<sub>2</sub>Cl<sub>2</sub></entry>
<entry>24</entry>
<entry>2</entry>
<entry>100</entry>
<entry>142</entry>
<entry>108, 25.6</entry>
</row>
<row>
<entry>7-7</entry>
<entry>A</entry>
<entry>0.017</entry>
<entry>1:260</entry>
<entry>Toluene</entry>
<entry>24</entry>
<entry>2</entry>
<entry>100</entry>
<entry>19</entry>
<entry>337, 57.7</entry>
</row>
<row>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry/>
<entry>(bimodal)</entry>
</row>
<row>
<entry>7-8</entry>
<entry>C</entry>
<entry>0.017</entry>
<entry>1:260</entry>
<entry>Toluene</entry>
<entry>22</entry>
<entry>2</entry>
<entry>100</entry>
<entry>8</entry>
</row>
<row>
<entry>7-9</entry>
<entry>B</entry>
<entry>0017</entry>
<entry>1:260</entry>
<entry>Toluene</entry>
<entry>25</entry>
<entry>2</entry>
<entry>100</entry>
<entry>2</entry>
</row>
<row>
<entry namest="1" nameend="10" align="center" rowsep="1"/>
</row>
<row>
<entry namest="1" nameend="10" align="left" id="FOO-00001"><sup>a </sup>Mw = weight-average molecular weight. MWD = Mw/Mn (Mn = number-average molecular weight)</entry>
</row>
</tbody>
</tgroup>
</table>
</tables>
</p>
<?DETDESC description="Detailed Description" end="tail"?>
</description>
<us-chemistry idref="CHEM-US-00001" cdx-file="US07297805-20071120-C00001.CDX" mol-file="US07297805-20071120-C00001.MOL"/>
<us-chemistry idref="CHEM-US-00002" cdx-file="US07297805-20071120-C00002.CDX" mol-file="US07297805-20071120-C00002.MOL"/>
<us-chemistry idref="CHEM-US-00003" cdx-file="US07297805-20071120-C00003.CDX" mol-file="US07297805-20071120-C00003.MOL"/>
<us-chemistry idref="CHEM-US-00004" cdx-file="US07297805-20071120-C00004.CDX" mol-file="US07297805-20071120-C00004.MOL"/>
<us-chemistry idref="CHEM-US-00005" cdx-file="US07297805-20071120-C00005.CDX" mol-file="US07297805-20071120-C00005.MOL"/>
<us-chemistry idref="CHEM-US-00006" cdx-file="US07297805-20071120-C00006.CDX" mol-file="US07297805-20071120-C00006.MOL"/>
<us-chemistry idref="CHEM-US-00007" cdx-file="US07297805-20071120-C00007.CDX" mol-file="US07297805-20071120-C00007.MOL"/>
<us-claim-statement>What is claimed is:</us-claim-statement>
<claims id="claims">
<claim id="CLM-00001" num="00001">
<claim-text>1. A composition represented by the formula:</claim-text>
<claim-text><chemistry id="CHEM-US-00007" num="00007">
<img id="EMI-C00007" he="27.01mm" wi="69.93mm" file="US07297805-20071120-C00007.TIF" alt="embedded image" img-content="chem" img-format="tif"/>
</chemistry>
</claim-text>
<claim-text>where R<sup>1 </sup>and R<sup>2 </sup>are independently hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear and branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, C<sub>1 </sub>to C<sub>12 </sub>alkoxy, F, Cl, SO<sub>3</sub>, C<sub>1 </sub>to C<sub>12 </sub>perfluoroalkyl, and N(CH<sub>3</sub>)<sub>2</sub>,</claim-text>
<claim-text>R<sup>3 </sup>is independently selected from the group consisting of hydrogen, C<sub>1 </sub>to C<sub>12 </sub>linear or branched alkyl, C<sub>3 </sub>to C<sub>12 </sub>cycloalkyl, aryl, and 2,2,2-trifluoroethyl,</claim-text>
<claim-text>A is —CH(R<sup>4</sup>)—, —(CH<sub>2</sub>)<sub>x</sub>—, or —CY<sub>2</sub>CY<sub>2</sub>—, where R<sup>4 </sup>is a hydrocarbyl, halosubstituted hydrocarbyl, or alkoxy group of from 1 to 12 carbon atoms, x is an integer from 1 to 12, and Y is halogen,</claim-text>
<claim-text>and</claim-text>
<claim-text>X is halogen, triflate, acetate, trifluoroacetate, hydride, or tetrafluoroborate.</claim-text>
</claim>
<claim id="CLM-00002" num="00002">
<claim-text>2. The composition of <claim-ref idref="CLM-00001">claim 1</claim-ref> wherein A is —CH(R<sup>4</sup>)—; R<sup>3 </sup>is alkyl; and X is chlorine.</claim-text>
</claim>
<claim id="CLM-00003" num="00003">
<claim-text>3. The composition of <claim-ref idref="CLM-00002">claim 2</claim-ref> wherein R<sup>1 </sup>and R<sup>2 </sup>are hydrogen.</claim-text>
</claim>
<claim id="CLM-00004" num="00004">
<claim-text>4. The composition of <claim-ref idref="CLM-00002">claim 2</claim-ref> wherein R<sup>1 </sup>and R<sup>2 </sup>are methyl.</claim-text>
</claim>
<claim id="CLM-00005" num="00005">
<claim-text>5. The composition of <claim-ref idref="CLM-00003">claim 3</claim-ref> or <claim-ref idref="CLM-00004">4</claim-ref> wherein R<sup>3 </sup>is a C<sub>4 </sub>alkyl and R<sup>4 </sup>is a C<sub>4 </sub>hydrocarbyl.</claim-text>
</claim>
<claim id="CLM-00006" num="00006">
<claim-text>6. The composition of <claim-ref idref="CLM-00001">claim 1</claim-ref> wherein R<sup>1 </sup>and R<sup>2 </sup>are hydrogen; R<sup>3 </sup>is alkyl; A is —CY<sub>2</sub>CY<sub>2</sub>—; and X is chlorine.</claim-text>
</claim>
<claim id="CLM-00007" num="00007">
<claim-text>7. The composition of <claim-ref idref="CLM-00006">claim 6</claim-ref> wherein R<sup>3 </sup>is a C<sub>4 </sub>alkyl and A is —CF<sub>2</sub>CF<sub>2</sub>—.</claim-text>
</claim>
</claims>
</us-patent-grant>
